| Literature DB >> 31160837 |
Maria Vargas1, Annachiara Marra1, Pasquale Buonanno1, Carmine Iacovazzo1, Vincenzo Schiavone2, Giuseppe Servillo1.
Abstract
BACKGROUND AND AIM: Obstetric patients admitted to intensive care unit (ICU) represent a challenge to physicians. The purpose of this study is to evaluate the incidence, characteristics, and mortality of pregnant and postpartum patients requiring ICU admission.Entities:
Keywords: Intensive care unit; Obstetric patient; Postpartum patient; Tertiary care facility
Year: 2019 PMID: 31160837 PMCID: PMC6535986 DOI: 10.5005/jp-journals-10071-23163
Source DB: PubMed Journal: Indian J Crit Care Med ISSN: 0972-5229
Maternal characteristics and comorbidities
| Maternal age (y) | 31.8; 6.7; 18–44 | 32.9; 6.3; 18–44 | 30.2; 7; 19–43 | 0.095 |
| Body mass index (kg/m2) | 28.9; 5.3; 21.3–50.5 | 28.8; 4.2; 22.3–36.4 | 28.8; 6.6; 21.3–50.5 | 0.760 |
| Gestational age (y) | 33; 6; 35–37 | 34; 4; 25–40 | 30; 8, 4–40 | 0.098 |
| First pregnancy | 22; 33% | 12; 31% | 10; 36% | 0.928 |
| Patients with at least one previous cesarean section | 28; 43% | 22; 58% | 6; 21% | 0.006 |
| Multiple pregnancy[ | 5; 7% | 2;0,05% | 3; 0,1% | 0.721 |
| Heart disease | 10; 15% | 5; 13% | 5; 18% | 0.858 |
| Arterial hypertension | 2; 3% | 2; 3% | 0 | 0.612 |
| Hemostatic disorder | 5; 8% | 1; 5% | 4; 14% | 0.148 |
| Morbid obesity (BMI >35) | 2; 3% | 2; 5% | 0 | 0.612 |
| Asthma | 2; 3% | 1; 2.5% | 1; 3.5% | 0.612 |
| Autoimmune disease | 2; 3% | 1; 2.5% | 1; 3.5% | 0.612 |
| Hypothyroidism | 4; 6% | 3; 8% | 1; 3.5% | 0.467 |
| Malignancy | 3; 4% | 2; 5% | 1; 3.5% | 0.744 |
| Chronic renal failure | 1; 1% | 0 | 1; 3.5% | 0.876 |
| Diabetes mellitus type I | 1; 1% | 1; 2.5% | 0 | 0.876 |
| Chronic infection (HIV, HBV) | 2; 3% | 1; 2.5% | 1; 3.5% | 0.61 |
| Cerebrovascular accident | 2; 3% | 2; 5% | 0 | 0.612 |
| Others[ | 6; 9% | 4; 10% | 2; 7% | 0.964 |
**4 twin and one triplet pregnancies;
****Systemic mastocytosis, chronic venous insufficiency, chronic inflammatory demyelinating polyneuropathy, kidney stone, cerebral angiomatosis, cushing syndrome
Mode of delivery and anesthesiological procedures
| Vaginal delivery | 3; 5% | 2; 5% | 1; 4% | 0.708 |
| Cesarean section[ | 60; 95%
| 36; 95%
| 24; 96%
| 0.708 |
| Spinal/epidural anesthesia | 24; 40% | 14; 37% | 10; 40% | 1 |
| General anesthesia | 36; 60% | 22; 63% | 14; 60% | 0.912 |
| ASA I-II | 22; 37% | 12; 32% | 10; 40% | 0.677 |
| ASA III-IV | 36; 60% | 26;68% | 13; 52% | 0.294 |
| ASA V | 2; 3% | 0 | 2; 8% | 0.299 |
| Hysterectomy | 17; 27% | 17; 45% | 0 | 0.000 |
| Uterine artery embolization | 3; 5% | 3; 8% | 0 | 0.403 |
*According to Lucas classification of urgency of cesarean section
Intensive care unit admission diagnosis
| Hypertensive disease | 16/66(25%)
| Non obstetric sepsis
| 5/66 (7%)
|
| Major hemorrhage
| 20 (31%)
| Heart diseases
| 4/66 (6%)
|
*HELLP: Hemolysis, elevated liver enzymes, low platelets;
**AFLP: Acute fatty liver of pregnancy;
***DIC: Disseminated intravascular coagulation;
****Two cases of community acquired pneumonia (CAP, Streptococcus pneumonia) and one case of hospital acquired pneumonia (HAP, Pseudomonas aeruginosa)
Organ failures at the ICU admission
| Total | Obstetric admissions | Non obstetric admissions | p value | |
|---|---|---|---|---|
| Hemodinamic failure | 27; 41% | 23; 61% | 4; 14% | 0.011 |
| Respiratory failure | 12; 18% | 0 | 12; 43% | 0.000 |
| Hemodinamic and respiratory failure | 2; 3% | 1; 3% | 1; 4% | 0.831 |
| DIC/TTP/HUS[ | 9; 14% | 8; 21% | 1; 4% | 0.070 |
| Neurological dysfunction | 6; 9% | 4; 11% | 2; 7% | 0.665 |
| Hepatic failure | 2; 3% | 2; 5% | 0 | 0.229 |
| Acute kidney failure | 2; 3% | 0 | 2; 7% | 0.106 |
| Bowel obstruction | 1; 1% | 0 | 1; 4% | 0.248 |
| Postoperative monitoring | 5; 8% | 0 | 5; 18% | 0.012 |
*DIC: Disseminated intravascular coagulation; TTP: Thrombotic thrombocytopenic purpura; HUS: Hemolytic uremic syndrome
Characteristics and complications of ICU stay
| Antepartum admission (n; %) | 9; 14% | 0 | 9; 32% | 0.000 |
| Postpartum admission (n; %) | 57; 86% | 38; 100% | 17; 78% | 0.000 |
| HLOS (days) (mean; SD; range) | 18; 9; 1–50 | 20;9; 6–42 | 17; 10; 1–50 | 0.1793 |
| ILOS (days) (mean; SD; range) | 5; 4;1–29 | 5; 4; 2–23 | 4; 5;1–29 | 0.559 |
| Endotracheal Intubation at admission (n;%) | 35; 53% | 25; 66% | 10; 36% | 0.031 |
| SAPS II (mean; SD; range) | 26; 13; 16–36 | 28;12; 8–64 | 23; 15; 3–51 | 0.155 |
| TISS-24 (mean; SD; range) | 30; 11; 5–59 | 34; 11; 16–59 | 27;12; 5–56 | 0.019 |
| SOFA score (mean; SD; range) | 4;3; 0–12 | 5;3; 1–12 | 4; 3; 0–11 | 0.051 |
| Need for re-surgery | 10;15% | 5;13% | 5;18% | 0.858 |
| PRES | 5; 8% | 5;13% | 0 | 0.127 |
| Acute renal failure | 4; 6% | 2; 5% | 2; 7% | 0.837 |
| Cerebral ictus (ischemic, hemorrhagic) | 3; 5% | 3; 8% | 0 | 0.332 |
| DIC | 2; 3% | 2; 13% | 0 | 0.612 |
| Postoperative paralytic ileus | 2: 3% | 2;13% | 0 | 0.612 |
| Miscellaneous[ | 2; 3% | 1; 3% | 1; 2% | 0.612 |
| Related to ICU stay | ||||
| CVC related infection | 2; 3% | 1; 3% | 1; 2% | 0.612 |
| VAP | 2; 3% | 1; 3% | 1; 2% | 0.612 |
| Pulmonary edema due to volume overload | 2; 3% | 2; 13% | 0 | 0.612 |
HLOS: Hospital length of stay; ILOS: ICU length of stay; SAPS II: Simplified acute physiology calculated on the worst values in the first 24 hours; TISS-24: Therapeutic intervention score system in the first 24 hour; SOFA: Severe organ failure assessment; PRES: Posterior reversible encephalopathy syndrome;
*Cerebral venous thrombosis and hepatorenal syndrome; DIC: Disseminated intravascular coagulation; VAP: Ventilatory associated pneumonia
History of previous cesarean section (CS) and outcome
| Non-obstetric admissions (n; %) | 28; 42% | 22; 48% | 6; 21% | 0.067 |
| Obstetric admissions (n; %) | 38; 57% | 16; 42% | 22; 79% | 0.067 |
| Major hemorrhage (n; %) | 20; 30% | 5; 13% | 15; 54% | 0.011 |
| Abnormal invasive placenta (placenta accreta and/or percreta) (n; %) | 9; 14% | 1; 20% | 8; 53% | 0.436 |
| Hysterectomy | 17; 26% | 1; 3% | 16; 57% | 0.000 |
| HLOS (mean, SD, range) | 28; 6; 1–55 | 19; 10; 1–50 | 18; 10; 7–42 | 0.988 |
| ILOS (mean; SD; range) | 37; 4; 1–27 | 5; 4; 1–29 | 4; 4; 2–23 | 0.798 |
| SAPS II, (predicted mortality %)
| 52; 15; 2–67 | 26; 13; 3–56 | 26; 14; 6–64 | 0.909 |
| Patients receiving red blood cells transfusion; (n; %) | 32; 48% | 14; 37% | 18; 61% | 0.050 |
| Patients receiving mechanical ventilation; (n; %) | 45; 68% | 24; 63% | 21; 78% | 0.451 |
| Patients developing at least one complication during ICU stay (n; %) | 21; 32% | 14; 37% | 7; 22% | 0.451 |